[Tolerance of the normocyclic sequence drug Oraconal and of various neutral hormones as well as of gestagen emphasizing contraceptive agents in the medical practice. Results of a group study of 173 established gynecologists involving 1539 women].
D000293:Adolescent; D000328:Adult; D001835:Body Weight / Q000187:drug effects; D003276:Contraceptives, Oral / Q000009:adverse effects / Q000627:therapeutic use*; D003863:Depression / Q000139:chemically induced; D004361:Drug Tolerance; D004967:Estrogens / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007989:Libido / Q000187:drug effects; D008598:Menstruation / Q000187:drug effects; D008599:Menstruation Disturbances / Q000139:chemically induced; D011372:Progestins / Q000009:adverse effects / Q000627:therapeutic use
D003276:Contraceptives, Oral; D004967:Estrogens; D011372:Progestins
Zur Veträglichkeit des normozyklischen Sequenzpräparates Oraconal und einiger hormonneutraler sowie gestagenbetonter Kontrazeptiva in der ärztlichen Praxis. Ergebnis einer Gemeinschaftsstudie von 173 niedergelassenen Gynäkologen an 1539 Frauen.